Streetbeat News

Regulatory

NKLA

Nikola Corporation has regained Nasdaq listing compliance, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 3:30 pm

AGEN

Agenus (NASDAQ:AGEN) has reported promising data from its Phase 1b trial on the botensilimab and balstilimab combination at the 2023 ESMO World Congress on Gastrointestinal Cancer. The data shows substantial survival benefits for patients with non-MSI-H metastatic colorectal cancer previously resistant to chemotherapy and/or immunotherapy. Agenus is planning to submit its first Biologics License Application to the FDA for patients with non-MSI-H metastatic colorectal cancer.

Portfolio Pulse from Happy Mohamed

June 30, 2023 | 3:21 pm

SRRK

Scholar Rock (NASDAQ:SRRK) has announced new data from the Phase 2 TOPAZ trial extension period evaluating patient outcomes at 36 months of treatment with apitegromab. The data showed that continued treatment with apitegromab was associated with substantial and sustained improvement in motor function in patients with nonambulatory Types 2 and 3 spinal muscular atrophy (SMA). The company is progressing with the enrollment in the pivotal Phase 3 SAPPHIRE registrational trial, with completion anticipated in Q3 2023.

Portfolio Pulse from Happy Mohamed

June 30, 2023 | 3:01 pm

SOFI

SoFi shares are trading higher after the US Supreme Court blocked Biden's student loan forgiveness program. This decision could potentially increase the demand for SoFi's loan refinancing services.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 2:46 pm

NAVI

SLM

SOFI

SPY

The U.S. Supreme Court has ruled against President Biden's plan to cancel $430 billion in student loan debt. This is the first of two challenges to the plan.

Portfolio Pulse from Benzinga Newsdesk

June 30, 2023 | 2:43 pm

SLM

SOFI

SPY

The U.S. Supreme Court has ruled in favor of President Biden's plan to cancel $430 billion in student loan debt. This is the first of two challenges to the plan.

Portfolio Pulse from Happy Mohamed

June 30, 2023 | 2:34 pm

FRHC

Citron Research has expressed suspicion that Freedom Holding Corp. (FRHC) may be under investigation by US government agencies such as the SEC, Treasury, or DOJ. Citron believes that FRHC might be withholding crucial information from its shareholders.

Portfolio Pulse from Happy Mohamed

June 30, 2023 | 2:33 pm

FRHC

Citron Research has raised concerns about Freedom Holdings' potential acquisition of a US brokerage firm in Maxim, citing the company's failure to file a 10k, missed extension deadlines, departure of their auditor, and sanctions and suspensions by the PCAOB. Citron also questioned the lack of regulatory intervention from the SEC, NASDAQ, and DOJ, and called for increased accountability and scrutiny of companies like Freedom Holdings.

Portfolio Pulse from Happy Mohamed

June 30, 2023 | 2:24 pm

DSS

DSS Inc. has announced an updated shareholder of record date for the spinoff of Impact BioMedical Inc. to July 10, 2023, pending SEC clearance. Shareholders of DSS Inc. on record as of July 10, 2023, will receive four shares of Impact Biomedical Inc. for every one share of DSS, Inc. on a future distribution date. The distribution is subject to the already filed S-1 being declared effective for registering the distribution.

Portfolio Pulse from Happy Mohamed

June 30, 2023 | 2:22 pm

CCL

JOBY

MEDS

NERV

TNA

Benzinga's Stock Whisper Index highlights five stocks warranting attention for the week of June 29, 2023. These include Joby Aviation (JOBY), which saw shares soar after receiving a Special Airworthiness Certificate; Minerva Neurosciences (NERV), which saw shares rise after a $20 million investment; Carnival Corporation (CCL), which reported better-than-expected Q2 results; TRxADE Health (MEDS), which saw shares surge year-to-date but sold off after news of an acquisition; and Direxion Small Cap Bull 3X Shares (TNA), an ETF that saw a sharp rise in interest from readers.

Portfolio Pulse from Chris Katje

June 30, 2023 | 2:21 pm